Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 TU. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113105402B reveals a metal-free iodine-promoted route for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN113105402A reveals a metal-free iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles, offering cost-effective solutions for API manufacturing.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply chains.
Patent CN110467613B reveals a mild nickel-catalyzed route for isoindolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112239456B reveals a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112239456B details a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering high yields and simplified purification for reliable pharmaceutical intermediate supply chains.
Novel metal-free catalytic synthesis for high-purity pharmaceutical intermediates ensuring cost reduction and supply reliability for global drug development.
Patent CN108863969B reveals a mild Pd-catalyzed route for high-purity isoxazole intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN113105402B reveals a metal-free iodine-promoted synthesis for trifluoromethylated triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN113105402B details a metal-free iodine-promoted synthesis of trifluoromethylated triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN113105402B reveals a metal-free iodine-promoted route for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and simplified purification.
Patent CN112239456B details a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering high yields and scalable manufacturing for pharmaceutical intermediates.
Patent CN115215783B reveals novel copper-catalyzed synthesis for chiral oxindoles. Delivers high stereoselectivity and supply chain reliability for pharmaceutical manufacturing.
Patent CN115215783B reveals high-yield copper catalysis for chiral oxindoles. Enables cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113105402B reveals a metal-free route for 3,4,5-trisubstituted 1,2,4-triazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115215783B reveals novel copper-catalyzed synthesis for chiral oxindoles. Enables cost reduction in pharmaceutical intermediate manufacturing with high stereoselectivity.
Patent CN114409714B reveals a palladium-catalyzed route for planar chiral ferrocenes. This method offers high enantioselectivity and scalable manufacturing for global supply chains.
Patent CN111592486B reveals a metal-free route to 3,5-diarylpyridines using styrene and DMF, offering significant cost and supply chain advantages for API intermediates.
Patent CN112239456B details a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering high yields and simplified supply chains for API intermediates.
Patent CN113105402B reveals a metal-free iodine-promoted route for trifluoromethyl-triazoles, offering significant cost reduction and scalability for API manufacturing.